Brautbar, A., Virani, S. S., Belmont, J., Nambi, V., Jones, P. H., & Ballantyne, C. M. (2012). LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. The American Society for Biochemistry and Molecular Biology.
Chicago Style citaatBrautbar, Ariel, Salim S. Virani, John Belmont, Vijay Nambi, Peter H. Jones, en Christie M. Ballantyne. LPL Gene Variants Affect ApoC-III Response to Combination Therapy of Statins and Fenofibric Acid in a Randomized Clinical Trial of Individuals With Mixed Dyslipidemia. The American Society for Biochemistry and Molecular Biology, 2012.
MLA citatieBrautbar, Ariel, et al. LPL Gene Variants Affect ApoC-III Response to Combination Therapy of Statins and Fenofibric Acid in a Randomized Clinical Trial of Individuals With Mixed Dyslipidemia. The American Society for Biochemistry and Molecular Biology, 2012.